CUAJ – Review Nason et al Regionalization of testis cancer

At the Canadian Testis Cancer Workshop, the rationale and feasibility of regionalization of testis cancer care were discussed. The two-day workshop involved urologists, medical and radiation oncologists, pathologists, radiologists, physician’s assistants, residents and fellows, and nurses, as well as patients and patient advocacy groups. This review summarizes the discussion and recommendations of one of the central topics of the workshop — the centralization of testis cancer in Canada. It was acknowledged that non-guideline-concordant care in testis cancer occurs frequently, in the range of 18–30%. The National Health Service in the U.K. stipulates various testis cancer care modalities be delivered through supra-regional network. All cases are reviewed at a multidisciplinary team meeting and aspects of care can be delivered locally through the network. In Germany, no such network exists, but an insurance-supported online second opinion network was developed that currently achieves expert case review in over 30% of cases. There are clear benefits to regionalization in terms of survival, treatment morbidity, and cost. There was CUAJ – Review Nason et al Regionalization of testis cancer

[1]  C. Morash,et al.  Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum. , 2020, Current oncology.

[2]  E. Bass,et al.  Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. , 2019, The Journal of urology.

[3]  M. Wirth,et al.  Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review. , 2019, European urology oncology.

[4]  D. Siemens Are we ready to embark on further regionalization of urological surgery across Canada? , 2019, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[5]  D. Boffa,et al.  Motivators, Barriers, and Facilitators to Traveling to the Safest Hospitals in the United States for Complex Cancer Surgery , 2018, JAMA network open.

[6]  D. Berney,et al.  ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Gore,et al.  Disparities in Access and Regionalization of Care in Testicular Cancer , 2018, Clinical genitourinary cancer.

[8]  W. Cheung,et al.  A population-based analysis of urban–rural disparities in advanced pancreatic cancer management and outcomes , 2018, Medical Oncology.

[9]  S. Fosså,et al.  Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Burger,et al.  Are patients willing to travel for better ovarian cancer care? , 2018, Gynecologic oncology.

[11]  Y. Lotan,et al.  Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi‐Institutional Study , 2017, Clinical genitourinary cancer.

[12]  S. Loosen,et al.  Non–Guideline‐concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse‐free Survival , 2017, Clinical genitourinary cancer.

[13]  H. Kennecke,et al.  Impact of Travel Distance and Urban‐Rural Status on the Multidisciplinary Management of Rectal Cancer , 2017, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[14]  P. Austin,et al.  Regionalization and Outcomes of Lung Cancer Surgery in Ontario, Canada. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  E. Eltahawy,et al.  Reimbursements and frequency of tests in privately insured testicular cancer patients in the United States: Implications to national guidelines , 2017, Urology annals.

[16]  P. Pierorazio,et al.  Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer , 2017, The Journal of urology.

[17]  S. Fosså,et al.  Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Johansen,et al.  Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study. , 2017, European urology.

[19]  J. Pereira,et al.  Implementing the first regional hospice palliative care program in Ontario: the Champlain region as a case study , 2016, BMC Palliative Care.

[20]  R. Norman,et al.  A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[21]  A. Horwich,et al.  Guidelines on Testicular Cancer: 2015 Update. , 2015, European urology.

[22]  D. Sandberg Home Oxygen Program review: Regionalization in Vancouver Coastal Health and British Columbia , 2015, Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR.

[23]  P. Albers,et al.  German second-opinion network for testicular cancer: Sealing the leaky pipe between evidence and clinical practice , 2014, Oncology reports.

[24]  R. McLeod,et al.  Early results after regionalization of thoracic surgical practice in a single-payer system. , 2013, The Annals of thoracic surgery.

[25]  A. Horwich,et al.  The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature. , 2012, European urology.

[26]  R. Wahlqvist,et al.  Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  R. Huddart,et al.  Canadian consensus guidelines for the management of testicular germ cell cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[28]  N. Baxter,et al.  A Tale of Two Provinces: Regionalization of Pancreatic Surgery in Ontario and Quebec , 2011, Annals of Surgical Oncology.

[29]  R. Bremnes,et al.  Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  A. Oshima,et al.  Hospital procedure volume and prognosis with respect to testicular cancer patients: a population‐based study in Osaka, Japan , 2008, Cancer science.

[31]  M. Brouwers,et al.  Standards for thoracic surgical oncology in a single-payer healthcare system. , 2007, The Annals of thoracic surgery.

[32]  Guidelines Eau EUROPEAN ASSOCIATION OF UROLOGY , 2003 .

[33]  N. E. Hamilton Regionalization of trauma care: British Columbia, Canada. , 2002, The Journal of trauma.

[34]  L. Collette,et al.  Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. , 1999, Journal of the National Cancer Institute.

[35]  J. Tu,et al.  Coronary artery bypass mortality rates in Ontario. A Canadian approach to quality assurance in cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. , 1996, Circulation.

[36]  J. Reamy Health care in Canada: lessons for the United States. , 1991, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.